The emergence of ransomware attacks targeting critical infrastructure, enterprises, and government entities has prompted worldwide efforts to build resilience against cyber threats. Ransomware operates by encrypting files on an infected system and demanding payment, typically in cryptocurrency, in exchange for decryption. As ransomware gangs deploy more sophisticated tactics and demand larger sums to restore access and privacy, biodefense solutions offering endpoint detection, automated response, and readiness training have increased in importance. The global biodefense market encompasses a range of antivirus software, identity access management platforms, and vulnerability management tools that help organizations minimize damages from advanced persistent threats and supply chain compromises.
The global Biodefense Market is estimated to be valued at US$ 13.4 billion in 2023 and is expected to exhibit a CAGR of 15% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rising investments in biodefense capabilities - Factors like accelerating digitization of work environments and increasing dependence on online services amid the pandemic have significantly expanded the attack surface for cybercriminals. In response, governments worldwide are allocating greater budgets for cybersecurity preparedness to enforce multi-layered defenses, help critical sectors withstand future crises, and develop national cyber strategies. This boost in spending presents lucrative opportunities for biodefense solution providers.
Growing need for timely threat intelligence sharing - With ransomware syndicates conducting operations across borders and affiliates, real-time intelligence on fingerprinting, infrastructure analysis, and adversary behavior has become integral to disrupting criminal plans. However, siloed security operations hamper coordinated response globally. There is growing emphasis on public-private collaboration through information sharing centers and tech alliances to identify emerging threats jointly.
Porter’s Analysis
Threat of new entrants: The threat of new entrants is moderate due to high capital requirements to enter the market. Technical expertise and regulatory compliances also pose barriers for new players.
Bargaining power of buyers: The bargaining power of buyers is moderate as there are several established players in the market providing varied biodefense products and services.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as there are many raw material suppliers and manufacturers.
Threat of new substitutes: The threat of substitutes is low as biodefense products and services have no close substitutes fulfilling the same function.
Competitive rivalry: The competitive rivalry is high due to presence of many global and regional players competing on basis of innovation, quality and pricing.
Key Takeaways
The Global Biodefense Market Demand is expected to witness high growth. The market size was valued at US$ 13.4 Bn in 2023 and is forecasted to reach US$ 30.2 Bn by 2030, expanding at a CAGR of 15% during the forecast period.
Regional analysis: North America is expected to continue dominating the market during the forecast period supported by high defense spending, presence of major players and focus on combating biological threats. Asia Pacific is anticipated to be the fastest growing region due to increasing government initiatives, rising investments by key players and growing awareness.
Key players: Key players operating in the biodefense market are Ninebot, Xiaomi, Gitbot, He Robotics, Travelmate Robotics. These players are focusing on new product launches and partnerships with government agencies to strengthen their market presence.
Get more insights on this topic: https://www.insightprobing.com/biodefense-market-demand-share-analysis/
Global Biodefense market is valued at USD 5.31 Billion in 2018 and expected to reach USD 7.22 Billion by 2025 with the CAGR of 4.5 %over the forecast period.Favorable government initiatives, Increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense marketBiodefense constitutes the use of medical measures to protect individuals against bioterrorism including interventions such as drugs and vaccinations but also research and public health preparations to defend against such biological attack.
The goal of biodefense is to integrate the sustained efforts of the national and homeland security, medical, public health, intelligence, diplomatic, and law enforcement communities.
Biodefense is an emerging industry that offers new opportunities for both existing and new drug companies, as well as for biotechnology companies with technologies for drug discovery and pathogen detection.Get Sample Copy of This Premium Report: @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12902=SampleGlobal biodefense market report is segmented on the basis of product type, application and regional& country level.
On the basis of country level, market of Biodefense is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Biodefense CompaniesElusys Therapeutics, Inc.Emergent BioSolutions, Inc.DynPort Vaccine Company, LLCSIGA TechnologiesPharmAthene, Inc.Cleveland BioLabsIchor Medical SystemsAchaogen, Inc.Xoma CorporationDynavax Technologies CorporationBavarian Nordic others.Favorable government initiatives, increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense market.Favorable government initiatives, increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense market.
For instance, Centers for Disease Control and Prevention estimates, between 2016 and 2017, nearly 30 Million people suffered from influenza in the country.
For instance, according to the World Health Organization, More than 28,000 people were infected, and over 11,000 people died before the international public health emergency ended in June 2016.
